News

Published on 24 Nov 2023 on Insider Monkey via Yahoo Finance

ReShape Lifesciences Inc. (NASDAQ:RSLS) Q3 2023 Earnings Call Transcript


Article preview image

ReShape Lifesciences Inc. (NASDAQ:RSLS) Q3 2023 Earnings Call Transcript November 10, 2023

Operator: Good afternoon and thanks for joining the ReShape Lifesciences Third Quarter 2023 Conference Call. I would now like to turn the call over to Michael Miller from Rx Communications.

Michael Miller: Good afternoon, and thank you for joining the ReShape Lifesciences third quarter 2023 earnings call. I'm pleased to be joined today by Paul Hickey, President and Chief Executive Officer; and Tom Stankovich Chief Financial Officer. Paul will provide an overview and update on the company's activities, which will include a discussion with Dr. Caroline Apovian, a member of ReShape's Scientific Advisory Board. Then, Tom will review the financial results for the period. I'll then turn the call back over to Paul for some closing remarks, after which we'll open the call to a question-and-answer session. As a reminder, this conference call as well as ReShape Lifesciences' SEC filings and website, including the Investor Information section of the website, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

NASDAQ.RSLS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
ReShape Lifesciences Inc. (NASDAQ:RSLS) Q3 2023 Earnings Call Transcript

ReShape Lifesciences Inc. (NASDAQ:RSLS) Q3 2023 Earnings Call Transcript November 10, 2023 Operat...

Insider Monkey via Yahoo Finance 24 Nov 2023

ReShape Lifesciences Inc. (NASDAQ:RSLS) Q2 2023 Earnings Call Transcript

ReShape Lifesciences Inc. (NASDAQ:RSLS) Q2 2023 Earnings Call Transcript August 7, 2023 ReShape L...

Insider Monkey via Yahoo Finance 9 Aug 2023

Investors Continue Waiting On Sidelines For ReShape Lifesciences Inc. (NASDAQ:RSLS)

With a price-to-sales (or "P/S") ratio of 0.5x ReShape Lifesciences Inc. (NASDAQ:RSLS) may be sen...

Simply Wall St. via Yahoo Finance 19 Apr 2023

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.38% By Investing.com

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.38%

Investing.com 3 Feb 2023

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.40%

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.40%

Investing.com 4 Jan 2023

Here's Why Investors Should Retain Integra (IART) Stock for Now

Integra LifeSciences Holdings Corporation IART has been gaining from continued sales growth acros...

Zacks via Yahoo Finance 16 Sep 2022

ReShape Lifesciences' GIBI HD Calibration Tubes Scores FDA Approval For Tummy Tuck Procedures

ReShape Lifesciences Inc (NASDAQ: RSLS) has received FDA 510(k) clearance for the disposable Gast...

Benzinga via Yahoo Finance 10 Aug 2022

Here's Why You Should Retain Integra (IART) Stock For Now

Integra LifeSciences Holdings Corporation IART has been gaining from robust performance by the Co...

Zacks via Yahoo Finance 22 Apr 2022

Earnings Update: ReShape Lifesciences Inc. (NASDAQ:RSLS) Just Reported And Analysts Are Trimming...

ReShape Lifesciences Inc. (NASDAQ:RSLS) missed earnings with its latest full-year results, disapp...

Simply Wall St. via Yahoo Finance 31 Mar 2022

20 Stocks Moving in Tuesday's Pre-Market Session

Don’t forget to check out our premarket coverage here .

Benzinga 29 Mar 2022